The Cell counting market growth in 2026 involves determining the number of cells in a sample and assessing characteristics such as cell viability and movement. It is an essential process in laboratory research, clinical testing, and biopharmaceutical production. Researchers use cell counting to monitor cell growth, evaluate experimental results, and support drug development. Manufacturers also rely on consistent cell measurements to maintain production processes and minimize waste. The increasing use of cell-based research and advanced therapies is creating opportunities for instruments, consumables, and accessories across the industry.
According to Fortune Business Insights, the global cell counting market size was valued at USD 11.94 billion in 2025 and is projected to grow from USD 12.86 billion in 2026 to USD 24.45 billion by 2034, exhibiting a CAGR of 8.4% during the forecast period. North America dominated the global market with a share of 36.85% in 2025. Increasing investments in pharmaceutical research, biopharmaceutical manufacturing, and cell-based therapies are supporting demand for advanced cell counting solutions.
The global cell counting market includes established life science, laboratory equipment, and analytical technology companies. Major participants identified by Fortune Business Insights include:
These companies compete through product development, automated laboratory systems, improved analytical capabilities, and strategic collaborations. Their solutions serve academic research, clinical diagnostics, and pharmaceutical manufacturing, where consistent cell measurements are important for reliable workflows.
Market Drivers